Fundraising Fox
🦊/Companies
Sign in

Samsara

Boston, US · 4 known investors

Find your way into Samsara

Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.

BiotechDeep TechLongevity

Investors · 4

Apollo Health Ventures✓ verifiedBerlin
CoastCapVienna
Korify Capital
Andreessen HorowitzreportedMenlo Park · $500K – $50M

In the news

BNP Paribas Exane raises Samsara stock price target on growth By Investing.cominvesting.com · Sep 2026BofA raises Samsara stock price target to $55 on strong results By Investing.cominvesting.com · Sep 2026Why is Samsara stock surging today? By Investing.cominvesting.com · Sep 2026Samsara reports 30% ARR growth, adds record large customers By Investing.cominvesting.com · Sep 2026Samsara soars on strong earnings beat and solid guide By Investing.cominvesting.com · Sep 2026Samsara revenue jumps 31%, raises annual outlook on AI momentumfinance.yahoo.com · Jun 2026Samsara IPOs at $11.5B valuationbarrons.com · Dec 2021Frameworks from a growth leader who helped Samsara scale from Series A–Series Fjunglegym.substack.com · Oct 2020

Frequently asked questions

What does Samsara do?
Samsara Therapeutics develops small-molecule therapeutics that activate autophagy to slow the progression of age-related neurodegenerative diseases such as ALS, Parkinson's, and Charcot-Marie-Tooth disease. It runs an in-house phenotypic screening platform using patient-derived iPSCs to identify and validate autophagy activators for drug discovery.
Who are Samsara's investors?
Samsara's investors include Apollo Health Ventures, CoastCap, Korify Capital, Andreessen Horowitz.
Where is Samsara headquartered?
Samsara is headquartered in Boston, US.